Per Odin
51 – 60 of 179
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease : Real-World Evidence From G7 Countries
Antonini, Angelo ; Pahwa, Rajesh ; Odin, Per LU
; Henriksen, Tove
; Soileau, Michael J.
; Rodriguez-Cruz, Ramon
; Isaacson, Stuart H.
; Merola, Aristide
; Lindvall, Susanna
and Domingos, Josefa
, et al.
(2022)
In Neurology and Therapy
11(1).
p.303-318
- Contribution to journal › Article
-
Mark
Insights on Genetic and Environmental Factors in Parkinson's Disease from a Regional Swedish Case-Control Cohort
Brolin, Kajsa LU
; Bandres-Ciga, Sara
; Blauwendraat, Cornelis
; Widner, Håkan
LU
; Odin, Per
LU
; Hansson, Oskar
LU
; Puschmann, Andreas
LU
and Swanberg, Maria
LU
(2022)
In Journal of Parkinson's Disease
12(1).
p.153-171
- Contribution to journal › Article
-
Mark
Diagnostic work up : Laboratory and biomarkers
Cedergren Weber, Gustav and Odin, Per LU
(2022)
In International Review of Neurobiology
162.
p.53-96
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Does the 5–2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5–2-1-positive patients in 7 countries
Malaty, Irene A. ; Martinez-Martin, Pablo ; Chaudhuri, K. Ray ; Odin, Per LU
; Skorvanek, Matej
; Jimenez-Shahed, Joohi
; Soileau, Michael J.
; Lindvall, Susanna
; Domingos, Josefa
and Jones, Sarah
, et al.
(2022)
In BMC Neurology
22(1).
- Contribution to journal › Article
-
Mark
Gait and balance among people with de novo vs. mild to moderate Parkinson’s disease
Lindholm, Beata LU
; Hagell, Peter
LU
; Odin, Per
LU
; Dahlin, Lars
LU
and Franzén, Erika
(2022)
6th International Conference on Neurology and Brain Disorders (Virtual)
- Contribution to conference › Abstract
-
Mark
Why do ‘OFF’ periods still occur during continuous drug delivery in Parkinson’s disease?
Rota, Silvia ; Urso, Daniele ; van Wamelen, Daniel J. ; Leta, Valentina ; Boura, Iro ; Odin, Per LU
; Espay, Alberto J.
; Jenner, Peter
and Chaudhuri, K. Ray
(2022)
In Translational Neurodegeneration
11(1).
- Contribution to journal › Scientific review
-
Mark
Effects of Levodopa-Carbidopa Intestinal Gel on Dyskinesia and Non-Motor Symptoms Including Sleep : Results from a Meta-Analysis with 24-Month Follow-Up
Chaudhuri, K. Ray ; Antonini, Angelo ; Pahwa, Rajesh ; Odin, Per LU
; Titova, Nataliya
; Thakkar, Sandeep
; Snedecor, Sonya J.
; Hegde, Saket
; Alobaidi, Ali
and Parra, Juan Carlos
, et al.
(2022)
In Journal of Parkinson's Disease
12(7).
p.2071-2083
- Contribution to journal › Scientific review
-
Mark
High risk of developing dementia in Parkinson’s disease : a Swedish registry-based study
Åström, Daniel Oudin LU ; Simonsen, Jacob ; Raket, Lars Lau LU
; Sgarbi, Simona
; Hellsten, Johan
LU
; Hagell, Peter
LU
; Norlin, Jenny M.
; Kellerborg, Klas
; Martinez-Martin, Pablo
and Odin, Per
LU
(2022)
In Scientific Reports
12(1).
- Contribution to journal › Article
-
Mark
Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease
Bergquist, Filip ; Ehrnebo, Mats ; Nyholm, Dag ; Johansson, Anders ; Lundin, Fredrik ; Odin, Per LU
; Svenningsson, Per
; Hansson, Fredrik
; Bring, Leif
and Eriksson, Elias
, et al.
(2022)
In Neurology
99(10).
p.965-976
- Contribution to journal › Article
-
Mark
Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson’s Disease : A Systematic Review and Bayesian Network Meta-analysis
Antonini, Angelo ; Pahwa, Rajesh ; Odin, Per LU
; Isaacson, Stuart H.
; Merola, Aristide
; Wang, Lin
; Kandukuri, Prasanna L.
; Alobaidi, Ali
; Yan, Connie H.
and Bao, Yanjun
, et al.
(2022)
In CNS Drugs
36(12).
p.1269-1283
- Contribution to journal › Scientific review